194 related articles for article (PubMed ID: 2519931)
41. Genetically engineered tumor vaccines.
Pardoll DM
Ann N Y Acad Sci; 1993 Aug; 690():301-10. PubMed ID: 7690216
[No Abstract] [Full Text] [Related]
42. [The use of monoclonal antibodies in the treatment of solid tumors].
Moiseenko VM
Vopr Onkol; 1999; 45(4):458-62. PubMed ID: 10532114
[No Abstract] [Full Text] [Related]
43. Update on tumor vaccines.
Stevenson FK
Int J Clin Lab Res; 1992; 22(2):84-9. PubMed ID: 1504310
[TBL] [Abstract][Full Text] [Related]
44. Pancreatic tumor antigens: diagnostic markers and targets for immunotherapy.
Finn OJ
Important Adv Oncol; 1992; ():61-77. PubMed ID: 1374733
[No Abstract] [Full Text] [Related]
45. Immunization effect of monoclonal antibodies against tumor-associated antigens during cancer treatment.
Fagerberg J; Frödin JE; Ragnhammar P; Steinitz M; Wigzell H; Mellstedt H
Ann N Y Acad Sci; 1993 Aug; 690():337-9. PubMed ID: 8368748
[No Abstract] [Full Text] [Related]
46. Tumour immunology: the end of the beginning.
Hall JG
Practitioner; 1982 Dec; 226(1374):2010-20. PubMed ID: 7170295
[No Abstract] [Full Text] [Related]
47. [Clinical trial of anti-idiotypic monoclonal antibodies in advanced melanoma].
Kageshita T; Hirai S; Ono T
Gan To Kagaku Ryoho; 1994 Feb; 21(2):163-9. PubMed ID: 8311486
[TBL] [Abstract][Full Text] [Related]
48. Cancer vaccines.
Pardoll DM
Immunol Today; 1993 Jun; 14(6):310-6. PubMed ID: 8397772
[TBL] [Abstract][Full Text] [Related]
49. Mimicry of the Hodgkin-associated IRAC antigen by an anti-idiotype network: potential use in active immunotherapy of Hodgkin's lymphoma.
Schobert I; Renner C; Pfreundschuh M; Diehl V; Pohl C
Leuk Lymphoma; 1994 May; 13(5-6):429-40. PubMed ID: 8069188
[TBL] [Abstract][Full Text] [Related]
50. A therapeutic human anti-idiotypic antibody mimics CD55 in three distinct regions.
Spendlove L; Li L; Potter V; Christiansen D; Loveland BE; Durrant LG
Eur J Immunol; 2000 Oct; 30(10):2944-53. PubMed ID: 11069077
[TBL] [Abstract][Full Text] [Related]
51. Colorectal cancer as a model for immunotherapy.
Foon KA; Yannelli J; Bhattacharya-Chatterjee M
Clin Cancer Res; 1999 Feb; 5(2):225-36. PubMed ID: 10037169
[No Abstract] [Full Text] [Related]
52. Idiotypic interactions in immune responses to tumor-associated antigens.
Lee VK; Hellström KE; Nepom GT
Biochim Biophys Acta; 1986 Oct; 865(2):127-39. PubMed ID: 3533153
[No Abstract] [Full Text] [Related]
53. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibody MK2-23: modulation of the immunogenicity in patients with malignant melanoma.
Mittelman A; Chen GZ; Wong GY; Liu C; Hirai S; Ferrone S
Clin Cancer Res; 1995 Jul; 1(7):705-13. PubMed ID: 9816036
[TBL] [Abstract][Full Text] [Related]
54. Monoclonal anti-idiotypic antibody mimicking the gastrointestinal carcinoma-associated epitope CO17-1A elicits antigen-specific humoral and cellular immune responses in colorectal cancer patients.
Birebent B; Mitchell E; Akis N; Li W; Somasundaram R; Purev E; Hoey D; Mastrangelo M; Maguire H; Harris DT; Nair S; Cai D; Zhang T; Herlyn DM
Vaccine; 2003 Apr; 21(15):1601-12. PubMed ID: 12639481
[TBL] [Abstract][Full Text] [Related]
55. Antigen mimicry by an anti-idiotypic antibody single chain variable fragment.
Tripathi PK; Qin H; Deng S; Xu C; Bhattacharya-Chatterjee M; Foon KA; Chatterjee SK
Mol Immunol; 1998 Sep; 35(13):853-63. PubMed ID: 9839554
[TBL] [Abstract][Full Text] [Related]
56. Anti-idiotype antibody vaccine therapy for cancer.
Bhattacharya-Chatterjee M; Chatterjee SK; Foon KA
Expert Opin Biol Ther; 2002 Dec; 2(8):869-81. PubMed ID: 12517266
[TBL] [Abstract][Full Text] [Related]
57. Immunotherapy of melanoma: peptide mimics of a human high molecular weight-melanoma associated antigen.
Wang X; Luo W; Ferrone S
Medicina (B Aires); 2000; 60 Suppl 2():48-50. PubMed ID: 11188931
[TBL] [Abstract][Full Text] [Related]
58. Tumor rejection antigens and tumor specific cytotoxic T lymphocytes.
Toes RE; Offringa R; Feltkamp MC; Visseren MJ; Schoenberger SP; Melief CJ; Kast WM
Behring Inst Mitt; 1994 Jul; (94):72-86. PubMed ID: 7998917
[TBL] [Abstract][Full Text] [Related]
59. Human high molecular weight-melanoma associated antigen mimicry by mouse anti-idiotypic monoclonal antibodies MK2-23. Experimental studies and clinical trials in patients with malignant melanoma.
Ferrone S; Chen ZJ; Liu CC; Hirai S; Kageshita T; Mittelman A
Pharmacol Ther; 1993; 57(2-3):259-90. PubMed ID: 8361995
[TBL] [Abstract][Full Text] [Related]
60. Suppressive versus augmenting effect of the same pretreatment regimen in two murine tumor systems with distinct effector mechanisms.
Fufiwara H; Hamaoka T; Kitagawa M
Gan; 1978 Dec; 69(6):793-803. PubMed ID: 312225
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
